Chan HK - Search Results

1

Treatment of infections caused by Gram-negative pathogens: current status on the pharmacokinetics/pharmacodynamics of parenteral and inhaled polymyxins in patients.

Lin YW, Aye SM, Rao G, Zhou QT, Chan HK, Li J. Lin YW, et al. Among authors: chan hk. Int J Antimicrob Agents. 2020 Dec;56(6):106199. doi: 10.1016/j.ijantimicag.2020.106199. Epub 2020 Oct 17. Int J Antimicrob Agents. 2020. PMID: 33075510 Free PMC article. Review.

2

Effect of device design on the aerosolization of a carrier-based dry powder inhaler--a case study on Aerolizer(®) Foradile (®).

Zhou QT, Tong Z, Tang P, Citterio M, Yang R, Chan HK. Zhou QT, et al. Among authors: chan hk. AAPS J. 2013 Apr;15(2):511-22. doi: 10.1208/s12248-013-9458-6. Epub 2013 Feb 1. AAPS J. 2013. PMID: 23371759 Free PMC article.

3

Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.

Zhou QT, Morton DA, Yu HH, Jacob J, Wang J, Li J, Chan HK. Zhou QT, et al. Among authors: chan hk. J Pharm Sci. 2013 Oct;102(10):3736-47. doi: 10.1002/jps.23685. Epub 2013 Jul 31. J Pharm Sci. 2013. PMID: 23904207

4

Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection.

Zhou QT, Gengenbach T, Denman JA, Yu HH, Li J, Chan HK. Zhou QT, et al. Among authors: chan hk. AAPS J. 2014 Jan;16(1):37-47. doi: 10.1208/s12248-013-9537-8. Epub 2013 Oct 16. AAPS J. 2014. PMID: 24129586 Free PMC article.

5

Advances in device and formulation technologies for pulmonary drug delivery.

Chan JG, Wong J, Zhou QT, Leung SS, Chan HK. Chan JG, et al. Among authors: chan hk. AAPS PharmSciTech. 2014 Aug;15(4):882-97. doi: 10.1208/s12249-014-0114-y. Epub 2014 Apr 12. AAPS PharmSciTech. 2014. PMID: 24728868 Free PMC article. Review.

6

Emerging inhalation aerosol devices and strategies: where are we headed?

Zhou QT, Tang P, Leung SS, Chan JG, Chan HK. Zhou QT, et al. Among authors: chan jg, chan hk. Adv Drug Deliv Rev. 2014 Aug;75:3-17. doi: 10.1016/j.addr.2014.03.006. Epub 2014 Apr 13. Adv Drug Deliv Rev. 2014. PMID: 24732364 Review.

7

Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.

Zhou QT, Sun SP, Chan JG, Wang P, Barraud N, Rice SA, Wang J, Li J, Chan HK. Zhou QT, et al. Among authors: chan jg, chan hk. Mol Pharm. 2015 Aug 3;12(8):2594-603. doi: 10.1021/mp500586p. Epub 2014 Dec 24. Mol Pharm. 2015. PMID: 25423590

8

Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.

Velkov T, Abdul Rahim N, Zhou QT, Chan HK, Li J. Velkov T, et al. Among authors: chan hk. Adv Drug Deliv Rev. 2015 May;85:65-82. doi: 10.1016/j.addr.2014.11.004. Epub 2014 Nov 12. Adv Drug Deliv Rev. 2015. PMID: 25446140 Free PMC article. Review.

9

Inhaled formulations and pulmonary drug delivery systems for respiratory infections.

Zhou QT, Leung SS, Tang P, Parumasivam T, Loh ZH, Chan HK. Zhou QT, et al. Among authors: chan hk. Adv Drug Deliv Rev. 2015 May;85:83-99. doi: 10.1016/j.addr.2014.10.022. Epub 2014 Oct 24. Adv Drug Deliv Rev. 2015. PMID: 25451137 Review.

10

Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder.

Chan JG, Tyne AS, Pang A, McLachlan AJ, Perera V, Chan JC, Britton WJ, Chan HK, Duke CC, Young PM, Traini D. Chan JG, et al. Among authors: chan hk, chan jc. Int J Antimicrob Agents. 2015 Mar;45(3):319-23. doi: 10.1016/j.ijantimicag.2014.11.009. Epub 2014 Dec 16. Int J Antimicrob Agents. 2015. PMID: 25554469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

540 results

Search Page